Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study

Nora Schwegel, Christina Toferer,David K. Zach, Viktoria Santner, Viktoria Hoeller, Jakob Lugitsch,Markus Wallner,Johannes Gollmer, Faisal Aziz,Dirk von Lewinski,Ewald Kolesnik,Klemens Ablasser,Andreas Zirlik, Harald Sourij,Nicolas Verheyen

JOURNAL OF CLINICAL MEDICINE（2024）

Cited 0|Views3

No score

Key words

transthyretin amyloid cardiomyopathy,Sodium-glucose co-transporter 2 inhibitors,survival,heart failure therapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined